588 related articles for article (PubMed ID: 25183244)
1. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.
Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P
Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset Still's disease.
Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
[TBL] [Abstract][Full Text] [Related]
4. Biologic treatments for adult-onset Still's disease.
Al-Homood IA
Rheumatology (Oxford); 2014 Jan; 53(1):32-8. PubMed ID: 23864171
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging biological therapy in adult-onset Still's disease.
Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
[TBL] [Abstract][Full Text] [Related]
6. About the complexity of adult onset Still's disease… and advances still required for its management.
Guilpain P; Le Quellec A
BMC Med; 2017 Jan; 15(1):5. PubMed ID: 28056958
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
8. Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.
Li S; Zheng S; Tang S; Pan Y; Zhang S; Fang H; Qiao J
Clin Rev Allergy Immunol; 2020 Feb; 58(1):71-81. PubMed ID: 31147820
[TBL] [Abstract][Full Text] [Related]
9. [Current concepts on the physiopathology of adult-onset Still's disease].
Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
[TBL] [Abstract][Full Text] [Related]
10. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Sfriso P; Bindoli S; Galozzi P
Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
Front Immunol; 2020; 11():603389. PubMed ID: 33552062
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adult-onset still's disease: up to date.
Yoo DH
Expert Rev Clin Immunol; 2017 Sep; 13(9):849-866. PubMed ID: 28540751
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
Kadavath S; Efthimiou P
Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
18. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
Bindoli S; Baggio C; Doria A; Sfriso P
Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
20. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]